©2025 Stanford Medicine
Memantine Augmentation in Obsessive-Compulsive Disorder
Not Recruiting
Trial ID: NCT00264238
Purpose
The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).
Official Title
An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder
Stanford Investigator(s)
John Barry, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult), Emeritus
Elias Aboujaoude, MD, MA
Clinical Professor, Psychiatry and Behavioral Sciences
Eligibility
Inclusion Criteria:
* at least 18 years of age
* suffering from OCD
* Y-BOCS score of 18 or greater
* taking a therapeutic dose of an anti-OCD medication specified in the protocol
Exclusion Criteria:
* diagnosed with a mental disorder other than OCD
* taking tiagabine or pregabalin
* having had a previous trial of memantine
* receiving therapy for OCD
* substance abuse in the last 6 months
* personality disorders sufficiently severe to interfere with study participation
Intervention(s):
drug: Memantine
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Nona Gamel
6507238601